Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients presenting with upper limb Areterio venous fistula / Arterioveous graft stenosis and undergoing angioplasty or surgery for correction of stenosis will be included in this study
Exclusion criteria
Exclusion criteria: Patients unwilling or having allergy to methotrexate will be excluded from the study. Patients with underlying myelo-suppression or deranged Liver function would be excluded Patients not having adequate result following angioplasty or surgery will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patency , diameter , flow rates would be assessed at presentation , at interval of 2 weeks till 6 months and if possible at eight months and twelve monthsTimepoint: At presentation and then at two weeks interval till 6 months and if possible at eight months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse events noted because of Methotrexate injection would be notedTimepoint: during the course of study upto 4 months | — |
Countries
India
Contacts
Armed Forces Medical Services